A. Brunetti

The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione- PPARg agonists

D. Foti, E. Chiefari, F. Paonessa, 2008 .

Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice

C. Croce, A. Fusco, D. Foti, 2005, Nature Medicine.

The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists.

A. Fusco, D. Foti, E. Chiefari, 2008, Endocrine-related cancer.

Gestational diabetes mellitus: an updated overview

A. Brunetti, B. Arcidiacono, D. Foti, 2017, Journal of Endocrinological Investigation.